Asymmetric Dimethylarginine, Plasma
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
An adjunct to other risk markers for assessing an individual's likelihood of future coronary events, in patients with coronary heart disease, type-II diabetes mellitus, or kidney disease
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Asymmetric Dimethyl Arginine, P
Asym dime arginine